Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2021

Mar 2, 2021

284_dirs_2021-03-02_4ff7afc4-8238-4003-bbdf-f813cb1638fb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2021-02-26

Reporting Person: Li Dean Y (Executive VP & President, MRL)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-26 Common Stock A 3485 $72.62 Acquired 10655.093 Direct

Footnotes

F1: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020.

F2: Holdings include shares acquired in dividend reinvestment transactions.